Trial Profile
Study of methylene blue (MB) to onabotulinum toxin A (BTX-A) solution in overactive bladder (OAB) treatment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Methylthioninium chloride (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics; Therapeutic Use
- 10 Aug 2018 New trial record